Enterprise Value
42.88M
Cash
639K
Avg Qtr Burn
-7.316M
Short % of Float
1.71%
Insider Ownership
0.07%
Institutional Own.
2.23%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phexxi™ Details Pregnancy Prevention | Approved Quarterly sales | |
EVO100 Details Sexually transmitted infections | Failed Discontinued | |
Phexxi™ Details Birth control, Urinary tract infection | Failed Discontinued |